Gland Pharma has reported results for third quarter ended December 31, 2022.
The company has reported fall of 16.77% in its net profit at Rs 227.54 crore for Q3FY23 as compared to Rs 273.38 crore for the corresponding quarter previous year. Total income of the company decreased by 10.96% to Rs 987.41 crore for the quarter under review as compared to Rs 1,108.99 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported fall of 15.05% in its net profit at Rs 231.95 crore for Q3FY23 as compared to Rs 273.03 crore for the same quarter in the previous year. Total income of the company decreased by 9.85% to Rs 999.80 crore for the quarter under review as compared to Rs 1,108.99 crore for the same quarter in the previous year.
